ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 657321 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 657321; 2) Community: the network communities that were significantly associated with the response to NSC 657321; 3) Molecule: the relationships between components within communities and NSC 657321; 4) MDR: the compounds that were significantly associated with the NSC 657321.

NSC Compound Enrichment Correlation
NSC 626879 Cyclopentanone, 2-[(dimethylamino)methyl]-5-heptylidene-, hydrochloride 0.0114553853234976 0.56869352
NSC 629595 Null 0.0114553853234976 0.60802537
NSC 630606 1-Piperidinecarboxylic acid, 3,5-bis(phenylmethylene)- 4-oxo-, 4-methylphenyl ester 0.0114553853234976 0.32486446
NSC 639520 Cyclohexanone, 2-[(2-methoxyphenyl)methylene]-5-[(4- morpholinyl)methyl]-, hydrochloride 0.0114553853234976 0.66988006
NSC 646159 Null 0.0114553853234976 0.50560441
NSC 266047 1,2-Cyclohexanediamine, platinum complex, (1R-trans)- (9CI) 0.0119653763676521 0.37601271
NSC 373355 Saframycin R 0.0119653763676521 0.45867118
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0119653763676521 -0.024767161
NSC 624902 Null 0.0119653763676521 0.57634376
NSC 649903 Null 0.0119653763676521 0.63185008
Total:106  Current:41    [First] [Prev] [Next] [Last]